Physician profile
Meredith Tussing
NPI 1154601987
$2,494.90
in general payments reported to CMS, 2019-2025
26 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $929 · 2022: $472 · 2023: $390 · 2024: $314 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $994 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $993.67 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $497.23 | 2021-2024 | |
| Astellas Pharma US INC | $400.01 | 2023-2025 | Veozah |
| Sage Therapeutics, LLC | $211.56 | 2021-2025 | Zurzuvae |
| Aspira Women'S Health INC | $180.41 | 2021-2024 | Ova1 |
| Therapeuticsmd, INC. | $148.03 | 2021-2022 | |
| Exeltis, USA INC. | $113.64 | 2022-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $109.96 | 2021-2024 | |
| Amgen INC. | $85.82 | 2021-2023 | Evenity, Prolia |
| Evofem Biosciences, INC. | $84.01 | 2021-2023 | Phexxi |
| Cumberland Pharmaceuticals, INC. | $77.44 | 2024-2025 | Kristalose |
| Pfizer INC. | $75.80 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $69.72 | 2021-2022 | |
| Avion Pharmaceuticals | $61.89 | 2021-2023 | Balcoltra |
| Coopersurgical, INC. | $60.15 | 2022-2023 | Summit Doppler, Paragard T 380a, Mara Console |
| Daiichi Sankyo INC. | $51.10 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $39.05 | 2021 | |
| Exact Sciences Corporation | $29.31 | 2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $28.80 | 2023 | Aptima, Thinprep 2000 Processor |
| Organon LLC | $28.73 | 2021-2022 | |
| Shield Therapeutics INC | $25.44 | 2023 | Accrufer |
| Optumhealth Care Solutions, LLC | $23.93 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Lilly USA, LLC | $21.70 | 2025 | Mounjaro, Zepbound |
| Sumitomo Pharma America, INC. | $21.37 | 2024 | Gemtesa |
| Mayne Pharma Commercial LLC | $18.87 | 2021 | |
| Agile Therapeutics, INC. | $16.45 | 2021 | |
| Scynexis, INC. | $14.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Tussing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.